Correction to:​ How has COVID-19 affected the treatment of osteoporosis? an IOF-NOF-ESCEO global survey

Fuggle, N. R.; Singer, A.; Gill, C.; Patel, A.; Medeiros, A.; Mlotek, A. S.; Pierroz, D. D.; Halbout, P.; Harvey, N. C.; Reginster, J.-Y.; Cooper, C.; Greenspan, S. L.

Affiliations

¹MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK

²Alan Turing Institute, London, UK

³Departments of Medicine and Obstetrics and Gynecology, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, DC, USA

⁴National Osteoporosis Foundation, Arlington, VA, USA

⁵International Osteoporosis Foundation, Nyon, Switzerland

⁶WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Liege, Belgium

⁷Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia

⁸NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK

⁹Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

Links

DOI: 10.1007/s00198-021-05905-7

PubMed: 33751152

WoS: 000626792300001

History

Online: 2021-03-09

Cited Works (1)

Year	Entry
2021	Fuggle NR, Singer A, Gill C, Patel A, Medeiros A, Mlotek AS, Pierroz DD, Halbout P, Harvey NC, Reginster J-Y, Cooper C, Greenspan SL. How has COVID-19 affected the treatment of osteoporosis? an IOF-NOF-ESCEO global survey. Osteoporos Int. April 2021;32(4):611-617.

Cited By (1)

Year	Entry
2021	Fuggle NR, Singer A, Gill C, Patel A, Medeiros A, Mlotek AS, Pierroz DD, Halbout P, Harvey NC, Reginster J-Y, Cooper C, Greenspan SL. How has COVID-19 affected the treatment of osteoporosis? an IOF-NOF-ESCEO global survey. Osteoporos Int. April 2021;32(4):611-617.